Related Experiment Video
Updated: Jul 7, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Factors affecting morbidity in chronic tuberculous empyema
Y Sonmezoglu1, A Turna, A Cevik
1Department of Thoracic Surgery, Yedikule Teaching Hospital for Chest Disease and Thoracic Surgery, Istanbul, Turkey. ysonmezoglu@ttnet.net.tr <ysonmezoglu@ttnet.net.tr>
Open drainage is a more effective treatment for chronic tuberculous empyema than the Eloesser flap. Pneumonectomy should be avoided due to higher complication rates in managing this condition.
Area of Science:
- Thoracic Surgery
- Infectious Diseases
- Pulmonary Medicine
Background:
- Chronic empyema is a known complication of pulmonary tuberculosis.
- Treatment strategies for chronic tuberculous empyema vary, with optimal approaches remaining unclear.
- This study investigates outcomes of different interventions for this condition.
Purpose of the Study:
- To compare the effectiveness of different surgical strategies for chronic tuberculous empyema.
- To evaluate the morbidity and complication rates associated with various treatment modalities.
- To identify the optimal management approach for chronic tuberculous empyema.
Main Methods:
- A cohort of 36 patients with chronic tuberculous empyema was studied retrospectively (1993-2002).
- Patients underwent open drainage, with 6 receiving Eloesser flap for persistent infection.
- Pneumonectomy was considered as a final therapeutic option for refractory cases.
Main Results:
- Open drainage showed significantly lower morbidity compared to Eloesser flap (P=0.011).
- Pneumonectomy was associated with increased postoperative complications (P=0.034).
- Extended antituberculosis therapy (≥6 months) trended towards reduced morbidity but was not statistically significant.
Conclusions:
- Open drainage is superior to Eloesser flap for managing chronic tuberculous empyema.
- Pneumonectomy should be reserved and avoided when possible due to its high complication rate.
- Further research may explore optimizing conservative management and adjunctive therapies.
Related Concept Videos
Tuberculosis
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
